DOI QR코드

DOI QR Code

Malignant Mesothelioma in Eastern Asia

  • Bianchi, Claudio (Center for the Study of Environmental Cancer, Italian League Against Cancer, Hospital of Monfalcone) ;
  • Bianchi, Tommaso (Center for the Study of Environmental Cancer, Italian League Against Cancer, Hospital of Monfalcone)
  • Published : 2012.10.31

Abstract

Relatively low numbers of malignant mesotheliomas have been reported from Eastern Asia. In order to explore the causes of this fact, the available data on mesothelioma incidence/mortality in five countries (Japan, South Korea, Taiwan, Hong Kong, and Singapore) were reviewed. Data on the industrial histories of the above countries were also examined. Mesothelioma incidence was low, despite a history of high shipbuilding and port activities, in which heavy exposure to asbestos generally has occurred. Underestimation of mesothelioma could partly explain the above discrepancy. Moreover, in some areas a sufficient latency period for mesothelioma development may have not yet elapsed, due to recent industrialization. However, other possibilities have to be considered. The cancer epidemiology in Eastern Asia differs deeply from that seen in Western countries, an indication of differences in etiologic factors of cancer as well as in co-factors. In addition, the oncogenic spectrum of asbestos is wide, and not completely defined. In a very different milieu from that of Western countries, asbestos could preferentially hit targets other than serosal membranes.

Keywords

References

  1. Aizawa S, Fukushima T, and the information management committee of the Japanese Society of Pathology (1997). A statistical analysis of computerized pathologic autopsy data in Japan from 1974 through 1993. Pathol Internat, 47, 126-46. https://doi.org/10.1111/j.1440-1827.1997.tb03731.x
  2. Baba K (1983). Indications of an increase of occupational pleural mesothelioma in Japan. J Uoeh, 5, 3-15.
  3. Bianchi C, Bianchi T (2007). Malignant mesothelioma: global incidence and relationship with asbestos. Ind Hlth, 45, 379-87. https://doi.org/10.2486/indhealth.45.379
  4. Bianchi C, Bianchi T (2008). Susceptibility and resistance in the genesis of asbestos-related mesothelioma. Indian J Occup Environ Med, 12, 57-60. https://doi.org/10.4103/0019-5278.43261
  5. Bianchi C, Bianchi T (2012). Shipbuilding and mesothelioma in Monfalcone, Italy. Indian J Occup Environ Med, 16, 14-7. https://doi.org/10.4103/0019-5278.99682
  6. Bianchi C, Bianchi T, Bucconi S (2010). Non-Hodgkin lymphoma of the testis and malignant mesothelioma of the pleura in the same patient. Eur J Oncol, 15, 167-71.
  7. Bianchi C, Bianchi T, Tommasi M (2007). Long latency periods in asbestos-related mesothelioma of the pleura. Eur J Oncol, 12, 189-95.
  8. Bianchi C, Brollo A, Ramani L, Bianchi T, Giarelli L (2001). Asbestos exposure in malignant mesothelioma of the pleura: a survey of 557 cases. Ind Hlth, 39, 161-7. https://doi.org/10.2486/indhealth.39.161
  9. Bianchi C, Brollo A, Ramani L, Bianchi T (2002). Concurrent malignant mesothelioma of the pleura and hepatocellular carcinoma in the same patient. A report of five cases. Ind Hlth, 40, 383-7. https://doi.org/10.2486/indhealth.40.383
  10. Bianchi C, Brollo A, Ramani L, Bianchi T (2004). Malignant mesothelioma of the pleura in Monfalcone, Italy. A 23-year monitoring in an area at high incidence. Eur J Oncol Library, 3, 49-58.
  11. Bianchi C, Ramani L, Bianchi T (2002). Latency periods in asbestos-related mesothelioma of the pleura (abstract). Med Lav, 93, 385.
  12. Chang HY, Wang JD, Chen CW, et al (2002). Asbestos in Taiwan: country report. In: Takahashi K, Lehtinen S, Karjalainen A (eds.). Proceedings of the Asbestos Symposium for the Asian Countries, September 26-27, 2002 Kitakyushu, Japan, J Uoeh, 24, 90-4.
  13. Chang KC, Leung CC, Tam CM, et al (2006). Malignant mesothelioma in Hong Kong. Respiratory Med, 100, 75-82. https://doi.org/10.1016/j.rmed.2005.04.017
  14. Chen J, Zhao W, Liu X, et al (2012). Clinical analysis of 45 patients with malignant pleural mesotelioma (in Chinese). Chin J Lung Cancer, 15, 97-102.
  15. Clin B, Morlais F, Launoy G, et al (2011). Cancer incidence within a cohort occupationally exposed to asbestos: a study of dose-response relationships. Occup Environ Med, 68, 832-6. https://doi.org/10.1136/oem.2010.059790
  16. Delgermaa V, Takahashi K, Park EK, et al (2011). HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/22084509" Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Hlth Organ, 89, 716-24. https://doi.org/10.2471/BLT.11.086678
  17. Encyclopaedia Britannica, Book of the Year (1983).
  18. Giarelli L, Bianchi C (2000). Geography of mesothelioma: expected findings and paradoxes. Eur J Oncol, 5, 77-81.
  19. Hilliard AK, Lovett JK, McGavin CR (2003). The rise and fall in incidence of malignant mesothelioma from a British Naval Dockyard, 1979-1999. Occup Med, 53, 209-12. https://doi.org/10.1093/occmed/kqg051
  20. Hiraoka T (1993). Endemic pleural plaques in the town of Kyushu, island of Japan. In: Gibbs GW, Kido M, Dunigann J, Higashi P (eds.). Health Risks from Exposure to Mineral Fibres: an International Perspective. Captus University Publications, North York (Ontario), 242-6.
  21. Hiraoka K, Horie A, Kido M (1990). Study of asbestos bodies in Japanese urban patients. Am J Ind Med, 18, 547-54. https://doi.org/10.1002/ajim.4700180505
  22. Ho SF, Lee HP, Phoon WH (1987). Malignant mesothelioma in Singapore. Br J Ind Med, 44, 788-9.
  23. Horii H, Nagasaka Y, Yamada Y (1992). Asbestos-related pleural thickenings in Japan sake brewers. Int Arch Occup Hlth, 64, 315-9. https://doi.org/10.1007/BF00379539
  24. IARC (2012). IARC monographs on the evaluation of carcinogenic risks to humans. A review of Human carcinogens: Metals, arsenic, dusts, and fibres. Lyon, WHO, IARC, 100 C.
  25. Iwasaki H, Jinpo S, Nata K (1955). An autopsy case of peritoneal mesothelioma. Acta Pathol Jpn, 5, 699-704.
  26. Jung SH (2011). Ten years experience of malignant mesothelioma surveillance in Korea. In "The 4th AAI International Seminar". "http://www.krcard.org/common_english/filedown.php?tid=board_dataroom2011_3&ono=30&n=1" http://www.krcard.org/common_english/filedown.php?tid=board_dataroom2011_3&ono=30&n=1.
  27. Kim YS (2011). Misdiagnosis of malignant pleural mesothelioma. In "The 4th AAI International Seminar". "http://www.krcard.org/common_english/filedown.php?tid=board_dataroom2011_3&ono=29&n=1" http://www.krcard.org/common_english/filedown.php?tid=board_dataroom2011_3&ono=29&n=1
  28. Kimizuka G, Hayashi Y (1983). Extraction of ferruginous bodies from lung tissue obtained at surgery and autopsy. Special reference to carcinoma of lung. Acta Pathol Jpn, 33, 715-24.
  29. Kishimoto T (1992). Intensity of exposure to asbestos in metropolitan area Kure City as estimated by autopsied cases. Cancer, 69, 2598-602. https://doi.org/10.1002/1097-0142(19920515)69:10<2598::AID-CNCR2820691033>3.0.CO;2-X
  30. Kishimoto T, Ono T, Okada K, Ito H (1989). Relationship between number of asbestos bodies in autopsy lung and pleural plaques on chest X-ray film. Chest, 95, 549-52. https://doi.org/10.1378/chest.95.3.549
  31. Kishimoto T, Ozaki S, Kato K, Nishi H, Genba K (2004). Malignant pleural mesothelioma in parts of Japan in relationship to asbestos exposure. Ind Hlth, 42, 435-9. https://doi.org/10.2486/indhealth.42.435
  32. Kohyama N (1989). Airborne asbestos levels in non-occupational environments in Japan. In: J. Mignon, J. Peto, and R. Saracci. Non-Occupational Exposure to Mineral Fibres. IARC, Lyon, IARC Sci Pub, 90, 262-76.
  33. Kurumatani N, Natori Y, Mizutani R, et al (1999). A historical cohort mortality study of workers exposed to asbestos in a refitting shipyard. Ind Hlth, 37, 9-17. https://doi.org/10.2486/indhealth.37.9
  34. Lam WK, Kung TM, Ma PL, So SY, Mok CK (1983). HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/6316591" First report of asbestos-related diseases in Hong Kong. Trop Geogr Med, 35, 225-9.
  35. Le GV, Takahashi K, Park EK, et al (2011). Asbestos use and asbestos-related diseases in Asia: Past, present and future. Respirology, 16, 767-75. https://doi.org/10.1111/j.1440-1843.2011.01975.x
  36. Lee KH, Yoon HS, Choi SJ, Kang D (2009). Asbestos exposure and malignant mesothelioma in Korea. Asian Pac J Cancer Prev, 10, 707-10.
  37. Lee LJH, Chang YY, Wang JD (2010). Impact of malignant mesothelioma in Taiwan: A 27-year review of populationbased cancer registry data. Lung Cancer, 68, 16-9. https://doi.org/10.1016/j.lungcan.2009.05.016
  38. Lin RT, Takahashi K, Karjalainen A, et al (2007). Ecological association between asbestos-related diseases and historical asbestos consumption: An international analysis. Lancet, 369, 844-9. https://doi.org/10.1016/S0140-6736(07)60412-7
  39. Matsukuma H, Tsuchiyama H, Kawai K, et al (1982). An autopsy case of diffuse pleural mesothelioma associated with pulmonary asbestosis: light and electron microscopic study. J Uoeh, 4, 65-80.
  40. Matsunaga H (1952). The peritoneal layer cell tumor. Especially on its histogenesis. Acta Pathol Jpn, 2, 73-80.
  41. Miura H, Kimula Y, Akabane H, Ishiwata H, Takabe K (1999). Clinical and pathological analysis of 48 malignant pleural mesothelioma cases in Miura peninsula, Kanagawa, Japan (Abstract). In: The 1st China-Japan Joint Asbestos Symposium, Beijing (China) 16-17 July, 29.
  42. Morinaga K (2009). Overview of epidemiology on asbestosrelated diseases in Japan-past, present, and the future (in Japanese). Japanese J Lung Cancer, 49, 39-47. https://doi.org/10.2482/haigan.49.39
  43. Morinaga K (2012). Personal communication.
  44. Morinaga K, Shinohara Y (2011). Asbestos pollution and its health effects: Asbestos-related diseases in Japan. In: Miyamoto K et al. (eds). Asbestos Disaster: Lessons from Japan Experience. Springer; 55-73.
  45. Murai Y, Kitagawa M, Hiraoka T (1995). Asbestos body formation in the human lung: distinctions, by type and size. Arch Environ Hlth, 50, 19-25. https://doi.org/10.1080/00039896.1995.9955008
  46. Murai Y, Kitagawa M, Hiraoka T (1997). Fiber analysis in lungs of residents of a Japanese town with endemic pleural plaques. Arch Environ Hlth, 52, 263-9. https://doi.org/10.1080/00039899709602196
  47. Murayama T, Takahashi K, Natori Y, Kurumatani N (2006). Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med, 49, 1-7. https://doi.org/10.1002/ajim.20246
  48. Natori Y, Ishiwata H, Akabane H, et al (1998). The relationship between shipyard works, asbestos-related pathological findings and number of asbestos bodies in autopsy lung. In: K. Chiyotani, Y. Hosoda, and Y. Aizawa. Advances in the Prevention of Occupational Respiratory Diseases, Elsevier Science, Amsterdam, 832-7.
  49. Nishikawa K, Takahashi K, Karjalainen A, et al (2008). Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment. Environ Hlth Perspect, 116, 1675-80. https://doi.org/10.1289/ehp.11272
  50. Ohar JA, Ampleford EJ, Howard SE, Sterling DA (2007). HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/16919927" Identification of a mesothelioma phenotype. Respir Med, 101, 503-9. https://doi.org/10.1016/j.rmed.2006.06.028
  51. Ohyagi S, Kagamimori S, Hillerdal G, et al (1985). Study on prevalence of pleural plaques in miniature x-ray films in Japan and Sweden. Ind Hlth, 23, 127-34. https://doi.org/10.2486/indhealth.23.127
  52. Paek D, Choi JK (2002). Asbestos in Korea: country report. In: Takahashi K, Lehtinen S, Karjalainen A (eds.). Proceedings of the Asbestos Symposium for the Asian Countries, September 26-27, 2002 Kitakyushu, Japan. J Uoeh, 24, 42-50.
  53. Park EK, Takahashi K, Hoshuyama T, et al (2011). HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/21463977" Global magnitude of reported and unreported mesothelioma. Environ Hlth Perspect, 119, 514-8. https://doi.org/10.1289/ehp.1002845
  54. Santibañez M, Alguacil J, Garcia de la Hera M, et al (2012). Occupational exposures and risk of stomach cancer by histological type. Occup Environ Med, 69, 268-75. https://doi.org/10.1136/oemed-2011-100071
  55. Shishido S, Iwai K, Tsukagoshi K (1990). Ferruginous bodies in the lungs of the general population during a 45-year period and mineralogical examination (in Japanese). Jap J Thor Dis, 28, 473-80.
  56. Stewart BW, Kleihues P (Eds.) (2003). World Cancer Report. Lyon, IARCPress.
  57. Tamura M, Kasuga H, Nishikawa K, et al (1992). Development and factors related to the appearance of diaphragmatic pleural calcification-Follow up study of employees in an asbestos plant (in Japanese). Jap J Thor Dis, 30, 230-7.
  58. Tossavainen A (2003). National mesothelioma incidence and the past use of asbestos. Monaldi Arch Chest Dis, 59, 146-9.
  59. Tossavainen A (2004). Global use of asbestos and the incidence of mesothelioma. Int J Occup Environ Hlth, 10, 22-5. https://doi.org/10.1179/oeh.2004.10.1.22
  60. Tse LA, Yu IT, Goggins W, et al (2010). Are current or future mesothelioma epidemics in Hong Kong the tragic legacy of uncontrolled use of asbestos in the past?. Environ Hlth Perspect, 118, 383-6. https://doi.org/10.1289/ehp.118-a383
  61. Utsumi K (1956). Three autopsy cases of mesothelioma (one of them treated with Au 188). Acta Pathol Jpn, 6, 271.
  62. Wei B, Jia X, Ye B, et al (2012). HYPERLINK "http://www. ncbi.nlm.nih.gov/pubmed/22760439" Impacts of land use on spatial distribution of mortality rates of cancers caused by naturally occurring asbestos. J Expo Sci Environ Epidemiol, 22, 516-21. https://doi.org/10.1038/jes.2012.63
  63. Yano E, Tanaka K, Funaki M, et al (1993). Effect of smoking on pleural thickening in asbestos workers. Br J Ind Med, 50, 898-901.
  64. Yip C SP, Koong HN, Loo CM, Fong KW (2011). Malignant pleural mesothelioma in Singapore. Asian Pac J Cancer Prev, 12, 1155-9.
  65. Yokoyama K, Morinaga K, Sera Y, Sakatani M (1993). A brief history of studies of asbestos-related diseases in Japan. In: Gibbs GW, Kido M, Dunigann J, Higashi P (eds.). Health Risks from Exposure to Mineral Fibres: an International Perspective. Captus University Publications, North York(Ontario), 281-3.

Cited by

  1. A Case of Lung Cancer Following the Surgical Removal of a Localized Malignant Mesothelioma vol.53, pp.3, 2013, https://doi.org/10.2482/haigan.53.245
  2. Malignant mesothelioma with fungating masses and multiple sites involvement vol.11, pp.4, 2015, https://doi.org/10.1111/crj.12383
  3. Expression, Purification and Immunogenic Description of a Hepatitis C Virus Recombinant CoreE1E2 Protein Expressed by Yeast Pichia pastoris vol.8, pp.4, 2015, https://doi.org/10.5812/jjm.8(4)2015.17157
  4. Asbestos treatment technologies pp.1611-8227, 2019, https://doi.org/10.1007/s10163-018-0793-7